Bibliography
- MURPHY PM, BAGGIOLINI M, CHARO IF et al.: International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors. (2000) Pharmacol Rev. 52: 145–176.
- •Detailed overview.
- MACKAY CR: Chemokines: immunology's high impact factors. Nat. Immunol (2001) 2:95–101.
- •Useful background review.
- TERAN LM: CCL chemokines and asthma. Immunol Today (2000) 5:235-42 (2000).
- JOSE P, GRIFFITHS-JOHNSON DA, COLLINS PD et al.: Eotaxin, a potent eosinophil chemoattractant cytokine detected in guinea-pig model of allergic airways inflammation. (1884) 1 Exp. Med. 179: 881–887.
- PONATH PD, QIN S, RINGLER DJ et al: Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin. Invest. (1996) 97:3604–3612.
- KITAURA M, SUZUKI N, IMAI T et al:Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3. Biol . Chem. (1999) 274:3927975–3927980.
- NAYA A, SAEKI T.: Chemokine CCR3 antagonists. Expert Opin. Titer. Patents (2004) 14 (1):7–16.
- ••Very up to date review of this area but withscant coverage of the Glaxo series of compounds.
- WACKER DA, SANTELLA JB, GARDNER DS et al.: CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure-activity relationships. Bioorg. Med. Chem. Lett. (2002) 12(13):1785–1789.
- DE LUCCA GV, KIM UT, JOHNSON C et al.: Discovery and structure-activity relationship of N-(ureidoalkyli-benzylpiperidines as potent small molecule CC chemokine receptor 3 (CCR3) antagonists. .1 Med Chem. (2002) 45:3794–3804.
- NAYA A, KOBAYASHI K, ISHIKAWA M et al: Structure-activity relationships of 2-(benzothiazolyl-thio)acetamide class of CCR3 selective antagonist. Chem. Pharm. Bull. (2003) 51(6):697–701.
- HODGSON S: CCR3 antagonists. 12th RSC-SCI Medicinal Chemistry Symposium, Cambridge UK September 2003.
- ••Discussion of the SAR of this series ofcompounds.
- NORMAN P: GlaxoSmithKline plc; Analysis of patenting 1998-2001 Expert Opin. Ther. Patents (2002) 12:1407–1415.